Loading…

Study on the Anticancer Activity of Coumarin Derivatives by Molecular Modeling

Protein kinase 2 (CK2) is a potential target, and the coumarins were identified as the attractive CK2 inhibitors. In this study, two models (CoMFA and CoMSIA) were established, and their reliabilities were supported by statistical parameters. From the CoMFA and CoMSIA models, the hydrophobic and hyd...

Full description

Saved in:
Bibliographic Details
Published in:Chemical biology & drug design 2011-10, Vol.78 (4), p.651-658
Main Authors: Huang, Xiao Y., Shan, Zhi J., Zhai, Hong L., Su, Li, Zhang, Xiao Y.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5565-2094261e0deb354aee42f0aad92ad6b0f5f08aa363195f3653e36f99f279dfef3
cites cdi_FETCH-LOGICAL-c5565-2094261e0deb354aee42f0aad92ad6b0f5f08aa363195f3653e36f99f279dfef3
container_end_page 658
container_issue 4
container_start_page 651
container_title Chemical biology & drug design
container_volume 78
creator Huang, Xiao Y.
Shan, Zhi J.
Zhai, Hong L.
Su, Li
Zhang, Xiao Y.
description Protein kinase 2 (CK2) is a potential target, and the coumarins were identified as the attractive CK2 inhibitors. In this study, two models (CoMFA and CoMSIA) were established, and their reliabilities were supported by statistical parameters. From the CoMFA and CoMSIA models, the hydrophobic and hydrogen bonds play very important roles in the interactions between inhibitors and CK2, which were confirmed sufficiently by molecular docking. Furthermore, the binding mode of the inhibitors at the active sites of CK2 was also investigated by docking study. The hydroxyl at the position R5 is more important for coumarins inhibitors because it forms hydrogen bonds not only with Lys68 as hydrogen acceptor but also with H2O as hydrogen donor. In addition, hydroxyl can make electrostatic interactions with electropositive Lys68 residue. The large group at the R6 position is not conducive to inhibitor dock into the groove of the binding site of CK2. When there is nitro group, the electrostatic interaction between ligand and receptor is enhanced significantly, and the nitro oxygen can form hydrogen bonds with the backbone NH of Lys68 and Asp175 simultaneously. The results obtained from molecular modeling techniques not only provide the models to predict the activity of inhibitors but also lead to a better understanding of the interactions between inhibitors and CK2, which will be very helpful for drug design. Based on the reliable CoMFA CoMSIA models established, several key factors and active cites were obtained and explored, which were confirmed by molecular docking.
doi_str_mv 10.1111/j.1747-0285.2011.01195.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_889176206</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1221136263</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5565-2094261e0deb354aee42f0aad92ad6b0f5f08aa363195f3653e36f99f279dfef3</originalsourceid><addsrcrecordid>eNqNkEtv1DAUha0K1Bf9C8g72CT4EdvxBmnI9EFbygJQl5YnuaYeMklrJ-3Mv8dh2llWWLJ8pHPuse6HEKYkp-l8WuZUFSojrBQ5I5Tm6WqRr_fQ4c54s9NKHaCjGJeEFIVg5T46YFRpSog-RDc_hrHZ4L7Dwx3gWTf42nY1BDyrB__oh2Q5XPXjygbf4TkE_2iTAREvNvhb30I9tjYk1UDru9_v0Ftn2wgnz-8x-nV2-rO6yK6_n3-tZtdZLYQUGSO6YJICaWDBRWEBCuaItY1mtpEL4oQjpbVc8rSW41Jw4NJp7ZjSjQPHj9GHbe996B9GiINZ-VhD29oO-jGastRUSUZkSn58NUkZo5RLJnmKlttoHfoYAzhzH3xafGMoMRN3szQTUjPhNRN384-7WafR98-_jIsVNLvBF9Ap8HkbePItbP672FRf5vNJpoJsW-DjAOtdgQ1_jFRcCXN7c25KdTVX4rIyl_wvu4GfnA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1221136263</pqid></control><display><type>article</type><title>Study on the Anticancer Activity of Coumarin Derivatives by Molecular Modeling</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Huang, Xiao Y. ; Shan, Zhi J. ; Zhai, Hong L. ; Su, Li ; Zhang, Xiao Y.</creator><creatorcontrib>Huang, Xiao Y. ; Shan, Zhi J. ; Zhai, Hong L. ; Su, Li ; Zhang, Xiao Y.</creatorcontrib><description>Protein kinase 2 (CK2) is a potential target, and the coumarins were identified as the attractive CK2 inhibitors. In this study, two models (CoMFA and CoMSIA) were established, and their reliabilities were supported by statistical parameters. From the CoMFA and CoMSIA models, the hydrophobic and hydrogen bonds play very important roles in the interactions between inhibitors and CK2, which were confirmed sufficiently by molecular docking. Furthermore, the binding mode of the inhibitors at the active sites of CK2 was also investigated by docking study. The hydroxyl at the position R5 is more important for coumarins inhibitors because it forms hydrogen bonds not only with Lys68 as hydrogen acceptor but also with H2O as hydrogen donor. In addition, hydroxyl can make electrostatic interactions with electropositive Lys68 residue. The large group at the R6 position is not conducive to inhibitor dock into the groove of the binding site of CK2. When there is nitro group, the electrostatic interaction between ligand and receptor is enhanced significantly, and the nitro oxygen can form hydrogen bonds with the backbone NH of Lys68 and Asp175 simultaneously. The results obtained from molecular modeling techniques not only provide the models to predict the activity of inhibitors but also lead to a better understanding of the interactions between inhibitors and CK2, which will be very helpful for drug design. Based on the reliable CoMFA CoMSIA models established, several key factors and active cites were obtained and explored, which were confirmed by molecular docking.</description><identifier>ISSN: 1747-0277</identifier><identifier>EISSN: 1747-0285</identifier><identifier>DOI: 10.1111/j.1747-0285.2011.01195.x</identifier><identifier>PMID: 21791009</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>anticancer activity ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Antitumor activity ; Casein Kinase II - antagonists &amp; inhibitors ; Casein Kinase II - metabolism ; CoMFA ; CoMSIA ; Coumarin ; Coumarins - chemistry ; Coumarins - pharmacology ; docking ; Drug Design ; Drug development ; Electrostatic properties ; Enzyme Inhibitors - chemistry ; Enzyme Inhibitors - pharmacology ; Humans ; Hydrogen ; Hydrogen bonding ; Hydrophobicity ; Models, Molecular ; Molecular modelling ; Neoplasms - drug therapy ; Oxygen ; Protein Binding ; Protein kinase ; protein kinase 2 ; Quantitative Structure-Activity Relationship ; Statistical analysis ; Statistics</subject><ispartof>Chemical biology &amp; drug design, 2011-10, Vol.78 (4), p.651-658</ispartof><rights>2011 John Wiley &amp; Sons A/S</rights><rights>2011 John Wiley &amp; Sons A/S.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5565-2094261e0deb354aee42f0aad92ad6b0f5f08aa363195f3653e36f99f279dfef3</citedby><cites>FETCH-LOGICAL-c5565-2094261e0deb354aee42f0aad92ad6b0f5f08aa363195f3653e36f99f279dfef3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27898,27899</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21791009$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huang, Xiao Y.</creatorcontrib><creatorcontrib>Shan, Zhi J.</creatorcontrib><creatorcontrib>Zhai, Hong L.</creatorcontrib><creatorcontrib>Su, Li</creatorcontrib><creatorcontrib>Zhang, Xiao Y.</creatorcontrib><title>Study on the Anticancer Activity of Coumarin Derivatives by Molecular Modeling</title><title>Chemical biology &amp; drug design</title><addtitle>Chem Biol Drug Des</addtitle><description>Protein kinase 2 (CK2) is a potential target, and the coumarins were identified as the attractive CK2 inhibitors. In this study, two models (CoMFA and CoMSIA) were established, and their reliabilities were supported by statistical parameters. From the CoMFA and CoMSIA models, the hydrophobic and hydrogen bonds play very important roles in the interactions between inhibitors and CK2, which were confirmed sufficiently by molecular docking. Furthermore, the binding mode of the inhibitors at the active sites of CK2 was also investigated by docking study. The hydroxyl at the position R5 is more important for coumarins inhibitors because it forms hydrogen bonds not only with Lys68 as hydrogen acceptor but also with H2O as hydrogen donor. In addition, hydroxyl can make electrostatic interactions with electropositive Lys68 residue. The large group at the R6 position is not conducive to inhibitor dock into the groove of the binding site of CK2. When there is nitro group, the electrostatic interaction between ligand and receptor is enhanced significantly, and the nitro oxygen can form hydrogen bonds with the backbone NH of Lys68 and Asp175 simultaneously. The results obtained from molecular modeling techniques not only provide the models to predict the activity of inhibitors but also lead to a better understanding of the interactions between inhibitors and CK2, which will be very helpful for drug design. Based on the reliable CoMFA CoMSIA models established, several key factors and active cites were obtained and explored, which were confirmed by molecular docking.</description><subject>anticancer activity</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Antitumor activity</subject><subject>Casein Kinase II - antagonists &amp; inhibitors</subject><subject>Casein Kinase II - metabolism</subject><subject>CoMFA</subject><subject>CoMSIA</subject><subject>Coumarin</subject><subject>Coumarins - chemistry</subject><subject>Coumarins - pharmacology</subject><subject>docking</subject><subject>Drug Design</subject><subject>Drug development</subject><subject>Electrostatic properties</subject><subject>Enzyme Inhibitors - chemistry</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Humans</subject><subject>Hydrogen</subject><subject>Hydrogen bonding</subject><subject>Hydrophobicity</subject><subject>Models, Molecular</subject><subject>Molecular modelling</subject><subject>Neoplasms - drug therapy</subject><subject>Oxygen</subject><subject>Protein Binding</subject><subject>Protein kinase</subject><subject>protein kinase 2</subject><subject>Quantitative Structure-Activity Relationship</subject><subject>Statistical analysis</subject><subject>Statistics</subject><issn>1747-0277</issn><issn>1747-0285</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqNkEtv1DAUha0K1Bf9C8g72CT4EdvxBmnI9EFbygJQl5YnuaYeMklrJ-3Mv8dh2llWWLJ8pHPuse6HEKYkp-l8WuZUFSojrBQ5I5Tm6WqRr_fQ4c54s9NKHaCjGJeEFIVg5T46YFRpSog-RDc_hrHZ4L7Dwx3gWTf42nY1BDyrB__oh2Q5XPXjygbf4TkE_2iTAREvNvhb30I9tjYk1UDru9_v0Ftn2wgnz-8x-nV2-rO6yK6_n3-tZtdZLYQUGSO6YJICaWDBRWEBCuaItY1mtpEL4oQjpbVc8rSW41Jw4NJp7ZjSjQPHj9GHbe996B9GiINZ-VhD29oO-jGastRUSUZkSn58NUkZo5RLJnmKlttoHfoYAzhzH3xafGMoMRN3szQTUjPhNRN384-7WafR98-_jIsVNLvBF9Ap8HkbePItbP672FRf5vNJpoJsW-DjAOtdgQ1_jFRcCXN7c25KdTVX4rIyl_wvu4GfnA</recordid><startdate>201110</startdate><enddate>201110</enddate><creator>Huang, Xiao Y.</creator><creator>Shan, Zhi J.</creator><creator>Zhai, Hong L.</creator><creator>Su, Li</creator><creator>Zhang, Xiao Y.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201110</creationdate><title>Study on the Anticancer Activity of Coumarin Derivatives by Molecular Modeling</title><author>Huang, Xiao Y. ; Shan, Zhi J. ; Zhai, Hong L. ; Su, Li ; Zhang, Xiao Y.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5565-2094261e0deb354aee42f0aad92ad6b0f5f08aa363195f3653e36f99f279dfef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>anticancer activity</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Antitumor activity</topic><topic>Casein Kinase II - antagonists &amp; inhibitors</topic><topic>Casein Kinase II - metabolism</topic><topic>CoMFA</topic><topic>CoMSIA</topic><topic>Coumarin</topic><topic>Coumarins - chemistry</topic><topic>Coumarins - pharmacology</topic><topic>docking</topic><topic>Drug Design</topic><topic>Drug development</topic><topic>Electrostatic properties</topic><topic>Enzyme Inhibitors - chemistry</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Humans</topic><topic>Hydrogen</topic><topic>Hydrogen bonding</topic><topic>Hydrophobicity</topic><topic>Models, Molecular</topic><topic>Molecular modelling</topic><topic>Neoplasms - drug therapy</topic><topic>Oxygen</topic><topic>Protein Binding</topic><topic>Protein kinase</topic><topic>protein kinase 2</topic><topic>Quantitative Structure-Activity Relationship</topic><topic>Statistical analysis</topic><topic>Statistics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huang, Xiao Y.</creatorcontrib><creatorcontrib>Shan, Zhi J.</creatorcontrib><creatorcontrib>Zhai, Hong L.</creatorcontrib><creatorcontrib>Su, Li</creatorcontrib><creatorcontrib>Zhang, Xiao Y.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Chemical biology &amp; drug design</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huang, Xiao Y.</au><au>Shan, Zhi J.</au><au>Zhai, Hong L.</au><au>Su, Li</au><au>Zhang, Xiao Y.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Study on the Anticancer Activity of Coumarin Derivatives by Molecular Modeling</atitle><jtitle>Chemical biology &amp; drug design</jtitle><addtitle>Chem Biol Drug Des</addtitle><date>2011-10</date><risdate>2011</risdate><volume>78</volume><issue>4</issue><spage>651</spage><epage>658</epage><pages>651-658</pages><issn>1747-0277</issn><eissn>1747-0285</eissn><abstract>Protein kinase 2 (CK2) is a potential target, and the coumarins were identified as the attractive CK2 inhibitors. In this study, two models (CoMFA and CoMSIA) were established, and their reliabilities were supported by statistical parameters. From the CoMFA and CoMSIA models, the hydrophobic and hydrogen bonds play very important roles in the interactions between inhibitors and CK2, which were confirmed sufficiently by molecular docking. Furthermore, the binding mode of the inhibitors at the active sites of CK2 was also investigated by docking study. The hydroxyl at the position R5 is more important for coumarins inhibitors because it forms hydrogen bonds not only with Lys68 as hydrogen acceptor but also with H2O as hydrogen donor. In addition, hydroxyl can make electrostatic interactions with electropositive Lys68 residue. The large group at the R6 position is not conducive to inhibitor dock into the groove of the binding site of CK2. When there is nitro group, the electrostatic interaction between ligand and receptor is enhanced significantly, and the nitro oxygen can form hydrogen bonds with the backbone NH of Lys68 and Asp175 simultaneously. The results obtained from molecular modeling techniques not only provide the models to predict the activity of inhibitors but also lead to a better understanding of the interactions between inhibitors and CK2, which will be very helpful for drug design. Based on the reliable CoMFA CoMSIA models established, several key factors and active cites were obtained and explored, which were confirmed by molecular docking.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>21791009</pmid><doi>10.1111/j.1747-0285.2011.01195.x</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1747-0277
ispartof Chemical biology & drug design, 2011-10, Vol.78 (4), p.651-658
issn 1747-0277
1747-0285
language eng
recordid cdi_proquest_miscellaneous_889176206
source Wiley-Blackwell Read & Publish Collection
subjects anticancer activity
Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
Antitumor activity
Casein Kinase II - antagonists & inhibitors
Casein Kinase II - metabolism
CoMFA
CoMSIA
Coumarin
Coumarins - chemistry
Coumarins - pharmacology
docking
Drug Design
Drug development
Electrostatic properties
Enzyme Inhibitors - chemistry
Enzyme Inhibitors - pharmacology
Humans
Hydrogen
Hydrogen bonding
Hydrophobicity
Models, Molecular
Molecular modelling
Neoplasms - drug therapy
Oxygen
Protein Binding
Protein kinase
protein kinase 2
Quantitative Structure-Activity Relationship
Statistical analysis
Statistics
title Study on the Anticancer Activity of Coumarin Derivatives by Molecular Modeling
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-03-04T09%3A40%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Study%20on%20the%20Anticancer%20Activity%20of%20Coumarin%20Derivatives%20by%20Molecular%20Modeling&rft.jtitle=Chemical%20biology%20&%20drug%20design&rft.au=Huang,%20Xiao%20Y.&rft.date=2011-10&rft.volume=78&rft.issue=4&rft.spage=651&rft.epage=658&rft.pages=651-658&rft.issn=1747-0277&rft.eissn=1747-0285&rft_id=info:doi/10.1111/j.1747-0285.2011.01195.x&rft_dat=%3Cproquest_cross%3E1221136263%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5565-2094261e0deb354aee42f0aad92ad6b0f5f08aa363195f3653e36f99f279dfef3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1221136263&rft_id=info:pmid/21791009&rfr_iscdi=true